<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">RSX</journal-id>
<journal-id journal-id-type="hwp">sprsx</journal-id>
<journal-id journal-id-type="nlm-ta">Reprod Sci</journal-id>
<journal-title>Reproductive Sciences</journal-title>
<issn pub-type="ppub">1933-7191</issn>
<issn pub-type="epub">1933-7205</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1933719112450335</article-id>
<article-id pub-id-type="publisher-id">10.1177_1933719112450335</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Isoform Alpha of PKC May Contribute to the Maintenance of Pregnancy Myometrial Quiescence in Humans</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Jofré</surname>
<given-names>Nicolás M.</given-names>
</name>
<xref ref-type="aff" rid="aff1-1933719112450335">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Delpiano</surname>
<given-names>Ana M.</given-names>
</name>
<xref ref-type="aff" rid="aff1-1933719112450335">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cuello</surname>
<given-names>Mauricio A.</given-names>
</name>
<xref ref-type="aff" rid="aff1-1933719112450335">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Poblete</surname>
<given-names>José A.</given-names>
</name>
<xref ref-type="aff" rid="aff1-1933719112450335">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vargas</surname>
<given-names>Paula A.</given-names>
</name>
<xref ref-type="aff" rid="aff1-1933719112450335">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Carvajal</surname>
<given-names>Jorge A.</given-names>
</name>
<xref ref-type="aff" rid="aff1-1933719112450335">1</xref>
<xref ref-type="corresp" rid="corresp1-1933719112450335"/>
</contrib>
</contrib-group>
<aff id="aff1-1933719112450335">
<label>1</label>Unidad de Medicina Materno Fetal, División de Obstetricia y Ginecología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile</aff>
<author-notes>
<corresp id="corresp1-1933719112450335">Jorge A. Carvajal, Marcoleta 391, Centro de Investigaciones Médicas, Pontificia Universidad Católica de Chile, Santiago, Chile Email: <email>jcarva@med.puc.cl</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2013</year>
</pub-date>
<volume>20</volume>
<issue>1</issue>
<fpage>69</fpage>
<lpage>77</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Society for Gynecologic Investigation</copyright-holder>
</permissions>
<abstract>
<p>We postulate that protein kinase C α (PKCα) may contribute to the maintenance of pregnancy myometrial quiescence in humans. We studied the changes in myometrial PKCα gene products (messenger RNA [mRNA] and protein) in 4 groups of women: preterm not in labor (PT-NL), preterm in labor (PT-L), term not in labor (T-NL), and term in labor (T-L). The degree of PKCα activation was studied by comparing the levels of particulate (active) PKCα with the total PKCα protein levels and by measuring PKCα activity in the cytosolic and particulate fractions. Protein kinase Cα abundance (mRNA and protein) did not increase during myometrial quiescence (PT-NL), whereas the level of PKCα activity significantly increased during quiescence. The activity of PKCα significantly decreased in the T-NL, T-L, and PT-L groups. These findings suggest that PKCα plays a significant role in the maintenance of myometrial quiescence and that PKCα activity must decrease at the end of pregnancy allowing myometrial activation. Additionally, our data demonstrate an association between reduced PKCα activity and preterm labor, which merits further investigation.</p>
</abstract>
<kwd-group>
<kwd>protein kinase C α</kwd>
<kwd>myometrial quiescence</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1933719112450335">
<title>Introduction</title>
<p>The duration of pregnancy must be precisely regulated in mammals to ensure that the fetus remains in the uterus long enough to develop and acquire essential skills for extrauterine life. Despite the importance of the precise regulation of the duration of pregnancy and the extensive research in this area, the mechanisms that regulate the length of gestation in mammals, including humans, are not fully understood.<sup><xref ref-type="bibr" rid="bibr1-1933719112450335">1</xref></sup></p>
<p>Myometrial quiescence, a period of active myometrial relaxation, is one of the 4 stages of myometrial contractile activity during pregnancy.<sup><xref ref-type="bibr" rid="bibr2-1933719112450335">2</xref></sup> Myometrial quiescence begins at implantation and persists through approximately 36 weeks of gestation. Myometrial quiescence is characterized by the absence of contractions and refractoriness to contractile agonists. The mechanisms underlying myometrial quiescence are not fully understood, although many agents are suggested to play a role in this highly regulated process.<sup><xref ref-type="bibr" rid="bibr3-1933719112450335">3</xref></sup></p>
<p>The maintenance of myometrial quiescence is essential to regulate the duration of pregnancy. Normally, at the end of pregnancy, the myometrium recovers its contractile phenotype (myometrial activation) in preparation for labor (myometrial stimulation).<sup><xref ref-type="bibr" rid="bibr2-1933719112450335">2</xref>,<xref ref-type="bibr" rid="bibr4-1933719112450335">4</xref></sup> Therefore, the premature termination of myometrial quiescence could lead to the premature onset of labor.<sup><xref ref-type="bibr" rid="bibr5-1933719112450335">5</xref><xref ref-type="bibr" rid="bibr6-1933719112450335"/><xref ref-type="bibr" rid="bibr7-1933719112450335"/><xref ref-type="bibr" rid="bibr8-1933719112450335"/><xref ref-type="bibr" rid="bibr9-1933719112450335"/>–<xref ref-type="bibr" rid="bibr10-1933719112450335">10</xref></sup></p>
<p>To generate and maintain myometrial quiescence during pregnancy, a myometrial cellular pathway leading to the inhibition of the myometrial contractile phenotype must be activated. Indeed, several pathways have been proposed to play a role in the maintenance of myometrial quiescence.<sup><xref ref-type="bibr" rid="bibr3-1933719112450335">3</xref>,<xref ref-type="bibr" rid="bibr11-1933719112450335">11</xref>,<xref ref-type="bibr" rid="bibr12-1933719112450335">12</xref></sup> Among all of the proposed quiescence pathways, in this research, we proposed to study the role of protein kinase C (PKC) in the maintenance of human myometrial quiescence.</p>
<p>Protein kinase C belongs to a family of serine/threonine kinases that play an important role in controlling many cellular functions. At least 11 isoforms of PKC, which are encoded by 10 genes, have been identified in mammalian cells, and the isoforms differ in their biological function, localization, substrate specificity, and kinetic properties.<sup><xref ref-type="bibr" rid="bibr13-1933719112450335">13</xref></sup></p>
<p>The presence of at least 4 conventional (α, β-1, β-2, and γ), 3 novel (∊, δ, and μ), and 2 atypical (ι, ζ) isoforms of PKC have been reported in the human myometrium.<sup><xref ref-type="bibr" rid="bibr14-1933719112450335">14</xref><xref ref-type="bibr" rid="bibr15-1933719112450335"/><xref ref-type="bibr" rid="bibr16-1933719112450335"/>–<xref ref-type="bibr" rid="bibr17-1933719112450335">17</xref></sup> The role of PKC in myometrial contractility is debated; several investigators suggest that PKC inhibits myometrial contractility,<sup><xref ref-type="bibr" rid="bibr18-1933719112450335">18</xref>,<xref ref-type="bibr" rid="bibr19-1933719112450335">19</xref></sup> whereas others have indicated that PKC stimulates myometrial contractions.<sup><xref ref-type="bibr" rid="bibr15-1933719112450335">15</xref>,<xref ref-type="bibr" rid="bibr20-1933719112450335">20</xref><xref ref-type="bibr" rid="bibr21-1933719112450335"/>–<xref ref-type="bibr" rid="bibr22-1933719112450335">22</xref></sup></p>
<p>Because each of the PKC isoforms have unique cellular functions, it is necessary to identify the particular role of each isoform; certain isoforms may promote increased contractility, whereas others may be linked to reduced contractile activity.<sup><xref ref-type="bibr" rid="bibr23-1933719112450335">23</xref></sup> Changes in the expression or activity of the different PKC isoforms may regulate the contractile activity of the myometrium during pregnancy.</p>
<p>Studies of cardiovascular tissues demonstrated that the activated PKCα isoform inhibits smooth muscle contractility.<sup><xref ref-type="bibr" rid="bibr24-1933719112450335">24</xref><xref ref-type="bibr" rid="bibr25-1933719112450335"/><xref ref-type="bibr" rid="bibr26-1933719112450335"/>–<xref ref-type="bibr" rid="bibr27-1933719112450335">27</xref></sup> Protein kinase Cα is activated (translocated to the plasmatic membrane) when human myometrial cells in culture are stimulated with magnesium sulfate, which is a well-known tocolytic drug.<sup><xref ref-type="bibr" rid="bibr28-1933719112450335">28</xref></sup> Probably, PKCα inhibits myometrial contraction by PLC phosphorylation, thereby inhibiting the phosphatidylinositol signaling pathway.<sup><xref ref-type="bibr" rid="bibr19-1933719112450335">19</xref>,<xref ref-type="bibr" rid="bibr28-1933719112450335">28</xref></sup></p>
<p>We therefore postulate that the activation of PKCα contributes to the maintenance of myometrial quiescence during pregnancy; we also postulate that PKCα activity decreases at the end of pregnancy to allow myometrial activation and the onset of labor.</p>
</sec>
<sec id="section2-1933719112450335" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="section3-1933719112450335">
<title>Patients and Tissue Samples</title>
<p>The Institutional Review Board at the Pontificia Universidad Católica de Chile, where all samples were obtained, approved the study protocol. Women were included only after providing informed consent. Cesarean sections were indicated for medical reasons independent of this study. Myometrial samples were obtained from 4 groups of women: preterm not in labor (PT-NL), preterm in labor (PT-L), term not in labor (T-NL), and term in labor (T-L). Preterm samples are from women who delivered between 30 and 34 weeks of pregnancy, and term samples are from women who delivered between 38 and 40 weeks. Patients with preterm labor and concurrent clinical or laboratory signs of infection were excluded. All women included in the study were Hispanic. Myometrial samples were excised from the superior edge of the low transverse hysterotomy during cesarean delivery, frozen immediately in liquid nitrogen, and stored at −80°C until use.</p>
</sec>
<sec id="section4-1933719112450335">
<title>Protein kianse C Isoforms RT-PCR</title>
<p>Messenger RNA (mRNA) for all PKC isoforms was quantified by RT-PCR from the myometrial samples. Total RNA was extracted by the acid guanidinium thiocyanate–phenol–chloroform extraction method.<sup><xref ref-type="bibr" rid="bibr29-1933719112450335">29</xref></sup> The complementary DNA (cDNA) was synthesized from total RNA using the Superscript First-Strand Synthesis system (Invitrogen, Carlsbad, California). The reverse transcribed cDNA was amplified in a 25-uL PCR reaction containing 200 mmol/L dNTPs, 1 mmol/L of each primer, 100 ng cDNA, 2.5 U Taq DNA polymerase (Invitrogen), and 2 mmol/L MgCl<sub>2</sub>. The primers (<xref ref-type="table" rid="table1-1933719112450335">Table 1</xref>) were designed using primer 3 and based on published cDNA nucleotide sequences.<sup><xref ref-type="bibr" rid="bibr30-1933719112450335">30</xref></sup> The PCR bands were scanned, and the optical density of the bands was calculated. The arbitrary units of the optical density of each band were normalized by the optical density of the glyceraldehyde 3-phosphate dehydrogenase (GADPH) mRNA that was used as an internal control for each PCR.</p>
<table-wrap id="table1-1933719112450335" position="float">
<label>Table 1.</label>
<caption>
<p>Primer Pairs Used for RT-PCR</p>
</caption>
<graphic alternate-form-of="table1-1933719112450335" xlink:href="10.1177_1933719112450335-table1.tif"/>
<table>
<thead>
<tr>
<th>PKC Isoform</th>
<th colspan="2">Primer Sequence (5′ ↠ 3′)</th>
<th>Amplicon Length (bp)</th>
<th>Number of Cycles</th>
<th>Tm (°C)</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="2">α (alpha)</td>
<td>For</td>
<td>cga cgt gaa gga cca caa at</td>
<td rowspan="2">192</td>
<td rowspan="2">32</td>
<td rowspan="2">55</td>
</tr>
<tr>
<td>Rev</td>
<td>tca mtg tcg ggt ccc tta tc</td>
</tr>
<tr>
<td rowspan="2">β (beta)</td>
<td>For</td>
<td>tga agg gga gga tga aga tg</td>
<td rowspan="2">228</td>
<td rowspan="2">32</td>
<td rowspan="2">56</td>
</tr>
<tr>
<td>Rev</td>
<td>taa ggg ggc tgg atc tct tt</td>
</tr>
<tr>
<td rowspan="2">γ (gamma)</td>
<td>For</td>
<td>gct atc ggc ctc ttc ttc ct</td>
<td rowspan="2">229</td>
<td rowspan="2">34</td>
<td rowspan="2">55</td>
</tr>
<tr>
<td>Rev</td>
<td>aaa gga cca cca atc gac ag</td>
</tr>
<tr>
<td rowspan="2">δ (delta)</td>
<td>For</td>
<td>gaa gaa gac cgg agt tgc tg</td>
<td rowspan="2">214</td>
<td rowspan="2">33</td>
<td rowspan="2">53</td>
</tr>
<tr>
<td>Rev</td>
<td>gtc gat cag gac cac atc ct</td>
</tr>
<tr>
<td rowspan="2">∊ (epsilon)</td>
<td>For</td>
<td>gat gca gaa ggt cac tgc aa</td>
<td rowspan="2">249</td>
<td rowspan="2">32</td>
<td rowspan="2">55</td>
</tr>
<tr>
<td>Rev</td>
<td>gtc gtc atg gag gat gga ct</td>
</tr>
<tr>
<td rowspan="2">η (eta)</td>
<td>For</td>
<td>gaa cag agg ttc ggg atc aa</td>
<td rowspan="2">239</td>
<td rowspan="2">33</td>
<td rowspan="2">55</td>
</tr>
<tr>
<td>Rev</td>
<td>ata ttt ccg ggt tgg aga cc</td>
</tr>
<tr>
<td rowspan="2">θ (theta)</td>
<td>For</td>
<td>aca aac agg gct acc agt gc</td>
<td rowspan="2">250</td>
<td rowspan="2">34</td>
<td rowspan="2">52</td>
</tr>
<tr>
<td>Rev</td>
<td>atg cca cat gca tca cac tt</td>
</tr>
<tr>
<td rowspan="2">μ (mu)</td>
<td>For</td>
<td>acg gca cta ttg gag att gg</td>
<td rowspan="2">206</td>
<td rowspan="2">34</td>
<td rowspan="2">50</td>
</tr>
<tr>
<td>Rev</td>
<td>tga cca cat ttt ctc cca ca</td>
</tr>
<tr>
<td rowspan="2">ι (iota)</td>
<td>For</td>
<td>cgg cat gtg taa gga agg at</td>
<td rowspan="2">189</td>
<td rowspan="2">35</td>
<td rowspan="2">55</td>
</tr>
<tr>
<td>Rev</td>
<td>tcg gag ctc cca aca ata tc</td>
</tr>
<tr>
<td rowspan="2">ζ (zeta)</td>
<td>For</td>
<td>tca act gca aac tgc tgg tc</td>
<td rowspan="2">235</td>
<td rowspan="2">35</td>
<td rowspan="2">55</td>
</tr>
<tr>
<td>Rev</td>
<td>cca tcc atc cca tcg ata ac</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1933719112450335">
<p>The primers were designed based on published complementary DNA (cDNA) nucleotide sequences using primer3.<sup><xref ref-type="bibr" rid="bibr30-1933719112450335">30</xref></sup>
</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section5-1933719112450335">
<title>Protein Kinase Cα Western Blot</title>
<p>Samples of myometrium (50 μg of protein) were boiled (5 minutes, 90°C) in 6X loading buffer (60 mmol/L Tris-HCl, pH 6.8, 2% sodium dodecyl sulfate (SDS), 10% glycerol, 10% 2-mercaptoethanol), separated by SDS-polyacrylamide gel electrophoresis (PAGE; 10% polyacrylamide gel), and electrotransferred to nitrocellulose membranes. The nitrocellulose membranes were blocked with 5% nonfat milk in TBS-T (2 hours at room temperature). The membranes were incubated with anti-PKCα antibody (Santa Cruz Biotechnology, Santa Cruz, California) for 1.5 hours at room temperature (1:1000 dilution). The membranes were washed 4 times with TBS-T and incubated with horseradish peroxidase–conjugated antirabbit antibody, diluted 1:3000 in TBS-T (Millipore, Billerica, Massachusetts), for 1 hour at room temperature. After 4 washes of 15 minutes each with TBS-T, immunoreactive bands were detected using the Western Lightning-ECL Plus method (PerkinElmer Inc, Waltham, Massachusetts). Loading control was achieved by normalizing to β-actin. The optical density of the bands was measured for the quantitative analysis.</p>
</sec>
<sec id="section6-1933719112450335">
<title>Protein Kinase Cα Activity Estimation</title>
<p>The activity of PKCα was estimated by measuring the proportion of PKCα protein in the particulate and cytosolic fractions in the myometrial samples. The concentration of PKCα protein in the myometrial cellular fractions was measured by Western blot as previously described.<sup><xref ref-type="bibr" rid="bibr31-1933719112450335">31</xref></sup> The results are expressed as the percentage of particulate PKCα protein content over total PKCα protein (particulate + cytosolic). To prepare cellular fractions, myometrial samples (200 mg) were homogenized (0.3 mol/L sucrose, 10 mmol/L HEPES and 1 mmol/L EDTA; pH 7.4) in the presence of protease inhibitors and were subsequently centrifuged (700<italic>g</italic>, 10 minutes, 4°C). The supernatant was recovered and centrifuged again (100 000<italic>g</italic> 75 minutes, 4°C). The pellets and supernatants were recovered as particulate (membrane) and cytosolic fractions, respectively. Protein concentrations were determined by the Bradford method, and 25 mg protein was used in the Western blots. The purity of the fractions was checked by a Western blot of Na<sup>+</sup>/K<sup>+</sup> ATPase (Cell Signaling, Danvers, Massachusetts), which is a marker of the membrane fraction, and GADPH (Santa Cruz biotechnology, Inc), which is a marker of the cytosolic fraction (data not shown).</p>
</sec>
<sec id="section7-1933719112450335">
<title>Protein Kinase C activity assay in immunoprecipitates</title>
<p>Protein kinase Cα was immunoprecipitated in the cellular fractions using Protein G Sepharose Fast Flow (GE Healthcare Biosciences, Pittsburgh, Pennsylvania) following manufacturer instructions. Immune precipitates were resuspended in 20 µL to measure PKC activity. The activity of PKC was measured in the immunoprecipitates from the cellular fractions by a substrate phosphorylation assay using a PepTag non-radioactive PKC assay kit (Promega, Madison, Wisconsin), following the manufacturer’s instructions. Briefly, a 25-µL reaction was prepared containing the following: PKC reaction buffer, C1 peptide, PKC activator, peptide protection solution, and 9-µL sample. Reactions were initiated by the addition of the sample and terminated after 30 minutes by boiling. After adding 1 µL of 80% glycerol, the samples were separated by 0.8% agarose gel electrophoresis.</p>
</sec>
<sec id="section8-1933719112450335">
<title>Statistical Analysis</title>
<p>The sample size was calculated to detect a 25% increase in mRNA or protein levels among the groups with 80% power and 5% alpha error. We calculated the need of 5 patients in each group. The numerical averages were calculated for each group and compared to the preterm not-in-labor group (PT-NL). The results are expressed as such in the figures.</p>
<p>All data sets were subjected to a test of normalcy (Shapiro-Wilk test), and parametric or nonparametric tests were performed where appropriate. Statistical comparisons among multiple groups were conducted using a one-way analysis of variance (ANOVA) test followed by post hoc Student-Newman-Keuls (parametric) or a Kruskall-wallis one-way ANOVA on ranks test followed by Dunn multiple comparison tests (nonparametric). A 2-tailed <italic>P</italic> &lt; .05 was indicative of a statistically significant difference.</p>
</sec>
</sec>
<sec id="section9-1933719112450335">
<title>Results</title>
<sec id="section10-1933719112450335">
<title>Expression of Myometrial PKC Isoforms During Pregnancy</title>
<p>We observed all isoforms of PKC in all studied samples from the 4 analyzed groups using semiquantitative RT-PCR (<xref ref-type="fig" rid="fig1-1933719112450335">Figure 1</xref>). Myometrial expression of conventional PKC isoforms α (alpha) and β (beta) exhibited no significant variations during pregnancy or labor. We observed a significant increase in the expression of PKCγ (gamma) in the T-NL group (<xref ref-type="fig" rid="fig2-1933719112450335">Figure 2</xref>).</p>
<fig id="fig1-1933719112450335" position="float">
<label>Figure 1.</label>
<caption>
<p>All PKC isoforms were detected in human myometrium by RT-PCR. Agarose gel electrophoresis of the RT-PCR products to confirm their sizes and the identification of a single PCR product. PT-NL: indicates preterm not in labor; PT-L, preterm in labor; T-NL, term not in labor; T-L, term in labor; PKC, protein Kinase C.</p>
</caption>
<graphic xlink:href="10.1177_1933719112450335-fig1.tif"/>
</fig>
<fig id="fig2-1933719112450335" position="float">
<label>Figure 2.</label>
<caption>
<p>Relative abundance (compared with PT-NL mRNA) of mRNAs encoding PKC isoforms in human myometrium. Blots were quantified by densitometry using arbitrary optical density (OD) units; the OD units were averaged on each group. Data are expressed as the median + standard error. N = 10 for each group. PT-NL indicates  preterm not in labor; PT-L, preterm in labor; T-NL, term not in labor; T-L, term in labor; mRNA, messenger RNA; PKC, protein kinase C.</p>
</caption>
<graphic xlink:href="10.1177_1933719112450335-fig2.tif"/>
</fig>
<p>The novel isoforms of PKC δ (delta), ∊ (epsilon), η (eta), θ (theta), and μ (mu) were detected in similar levels among all 4 groups. Similarly, the mRNA levels of the atypical PKC isoforms, ι (iota) and ζ (zeta), did not change in any of the study groups (<xref ref-type="fig" rid="fig2-1933719112450335">Figure 2</xref>).</p>
</sec>
<sec id="section11-1933719112450335">
<title>Myometrial PKCα Protein Levels</title>
<p>We detected the presence of PKCα in the human myometrium in all studied samples from all groups (<xref ref-type="fig" rid="fig3-1933719112450335">Figure 3</xref>). However, PKCα protein levels did not exhibit any significant changes across groups (<xref ref-type="fig" rid="fig4-1933719112450335">Figure 4</xref>).</p>
<fig id="fig3-1933719112450335" position="float">
<label>Figure 3.</label>
<caption>
<p>Western blot of PKCα in human myometrium. Bands and representative immunoblots revealing the expression of PKCα protein. PT-NL: preterm not in labor; PT-L: preterm in labor; T-NL: term not in labor; T-L: term in labor; PKC, protein kinase C.</p>
</caption>
<graphic xlink:href="10.1177_1933719112450335-fig3.tif"/>
</fig>
<fig id="fig4-1933719112450335" position="float">
<label>Figure 4.</label>
<caption>
<p>Western blot analysis of PKCα in human myometrium. Quantification of Western blot signals compared to PT-NL. Blots were quantified by densitometry using arbitrary optical density (OD) units; the OD units were averaged on each group. Data are expressed as the median + standard error. N =10 in each group. PT-NL indicates preterm not in labor; PT-L: preterm in labor; T-NL: term not in labor; T-L: term in labor; PKC, protein kinase C.</p>
</caption>
<graphic xlink:href="10.1177_1933719112450335-fig4.tif"/>
</fig>
</sec>
<sec id="section12-1933719112450335">
<title>Myometrial PKCα Membrane Translocation</title>
<p>We observed PKCα in all studied cytosolic and membrane samples. The level of PKCα in the cytosolic fraction exhibited no significant variations between the groups. In contrast, we observed a significant reduction in the levels of PKCα in the particulate fractions of term samples, compared to PT-NL, regardless of whether the patient was in labor (<xref ref-type="fig" rid="fig5-1933719112450335">Figure 5</xref>).</p>
<fig id="fig5-1933719112450335" position="float">
<label>Figure 5.</label>
<caption>
<p>Western blot of PKCα in the cellular fractions of human myometrium. Bands and representative immunoblots demonstrating the expression of PKCα protein in the cytosolic and particulate fraction. C indicates cytosolic fraction; P, particulate fraction; PT-NL, preterm not in labor; PT-L, preterm in labor; T-NL, term not in labor; T-L, term in labor; PKC, protein kinase C.</p>
</caption>
<graphic xlink:href="10.1177_1933719112450335-fig5.tif"/>
</fig>
<p>To estimate the degree of PKCα activation, we calculated the proportion of PKCα protein levels in the particulate (active) fractions relative to the total PKCα protein content (particulate + cytosolic). In samples from patients in the myometrial quiescence period (PT-NL), nearly 60% of the PKCα protein was active (membrane/cytosol ratio). We observed that the degree of PKCα activation decreased at the end of pregnancy (T-NL and T-L) compared with preterm not-in-labor samples (PT-NL). Additionally, we observed a significant reduction in the degree of PKCα activation in the samples obtained after the premature onset of labor (PT-L; <xref ref-type="fig" rid="fig6-1933719112450335">Figure 6</xref>).</p>
<fig id="fig6-1933719112450335" position="float">
<label>Figure 6.</label>
<caption>
<p>Western blot analysis of PKCα in the cellular fractions of human myometrium. Quantification of Western blot signals compared to PT-NL. Blots were quantified by densitometry using arbitrary optical density (OD) units; the OD units were averaged on each group. Data are expressed as the median + standard error; n =10 in each group. PT-NL indicates preterm not in labor; PT-L, preterm in labor; T-NL, term not in labor; T-L, term in labor; ; PKC, protein kinase C.</p>
</caption>
<graphic xlink:href="10.1177_1933719112450335-fig6.tif"/>
</fig>
</sec>
<sec id="section13-1933719112450335">
<title>Myometrial PKCα Activity</title>
<p>We measured PKCα activity in the myometrial cellular fractions and observed that PKCα activity did not change in the cytosolic fraction. In the particulate fractions, PKCα activity was greater in the PT-NL samples and was significantly decreased in the T-NL and T-L groups (<xref ref-type="fig" rid="fig7-1933719112450335">Figure 7</xref>). Similar to the Western blot findings, the PKCα activity significantly decreased in samples from the preterm labor women (<xref ref-type="fig" rid="fig7-1933719112450335">Figure 7</xref>).</p>
<fig id="fig7-1933719112450335" position="float">
<label>Figure 7.</label>
<caption>
<p>Activity of PKCα assay in the cellular fractions of human myometrium. Quantification of signals compared to PT-NL. Data are expressed as the median + standard error; n = 6 in each group. The insert shows a representative gel. PT-NL indicates preterm not in labor; PT-L, preterm in labor; T-NL, term not in labor; T-L, term in labor; C1, PKC target peptide;. P-C1, phosphorylated PKC target protein.</p>
</caption>
<graphic xlink:href="10.1177_1933719112450335-fig7.tif"/>
</fig>
</sec>
</sec>
<sec id="section14-1933719112450335">
<title>Discussion</title>
<p>In this study, we demonstrated the presence of all PKC isoforms in human myometrium by RT-PCR, and we established that only PKCγ levels change significantly across the studied stages of myometrial activity during pregnancy. We also demonstrated that PKCα protein content did not change during those stages, but the degree of PKCα activation increased during the period of myometrial quiescence and decreased at the term of pregnancy, supporting our hypothesis of the role of PKCα in the maintenance of myometrial quiescence during pregnancy. Additionally, we observed a reduction in the degree of PKCα activation in the samples obtained after the premature onset of labor, suggesting that an anticipated reduction in PKCα activity may be etiologically related to preterm labor.</p>
<p>Other groups have studied PKC isoforms in the myometria of rodents and humans. In the rat myometrium, the presence of the isoforms α, β-II, δ, η, and ζ, traces of β-I, ∊ and γ has been described.<sup><xref ref-type="bibr" rid="bibr32-1933719112450335">32</xref></sup> In the human myometrium, the presence of 4 conventional (α, β-1, β-2, and γ), 3 new (∊, δ, and μ), and 2 atypical isoforms (ι and ζ) have been confirmed by Western blot.<sup><xref ref-type="bibr" rid="bibr14-1933719112450335">14</xref><xref ref-type="bibr" rid="bibr15-1933719112450335"/><xref ref-type="bibr" rid="bibr16-1933719112450335"/>–<xref ref-type="bibr" rid="bibr17-1933719112450335">17</xref></sup> By semiquantitative RT-PCR, conventional PKC isoforms have been detected in the human myometrium.<sup><xref ref-type="bibr" rid="bibr22-1933719112450335">22</xref>,<xref ref-type="bibr" rid="bibr33-1933719112450335">33</xref></sup> All of these studies, although relevant, do not provide knowledge about the role of PKC isoforms in the maintenance of myometrial quiescence because they only studied nonpregnant and term myometrium. In our study we evaluated for the first time the expression of PKC isoforms during the normal progression of pregnancy, from quiescence (PT-NL) to activation (T-NL) and stimulation (T-L). We also studied samples belonging to the pathological stage of the early termination of quiescence (preterm labor).</p>
<p>In our study, we detected the presence of the transcripts of all of the isoforms of PKC in the human myometrium. The only isoform that significantly increased its mRNA content was PKCγ, which exhibited increased levels at term before the onset of labor (T-NL); this pattern of expression suggests a role for PKCγ in the process of myometrial activation. Because we are studying the mechanisms underlying myometrial quiescence of pregnancy, we did not study PKCγ expression or activity as we did with PKCα.</p>
<p>We detected high levels of PKCα in all samples; however, the levels of PKCα (mRNA or protein) did not exhibit statistically significant changes across stages. The absence of increased PKCα expression during myometrial quiescence (PT-NL) could lead to discarding the possibility of it playing a role in the maintenance of myometrial quiescence; however, an alternative explanation is that the regulation of the biological action of PKCα lies primarily in the activation of previously synthesized proteins by phosphorylation and/or compartmentalization.</p>
<p>Cytosolic PKC is inactive; the pseudosubstrate region is coupled to the catalytic site of PKC, thereby preventing the binding of target proteins.<sup><xref ref-type="bibr" rid="bibr34-1933719112450335">34</xref></sup> The activation of PKC is achieved by its translocation to the plasma membrane,<sup><xref ref-type="bibr" rid="bibr28-1933719112450335">28</xref>,<xref ref-type="bibr" rid="bibr35-1933719112450335">35</xref></sup> where positive modulators (DAG, phospholipids) interact with PKC, removing the pseudosubstrate region from the catalytic site and thereby activating PKC.<sup><xref ref-type="bibr" rid="bibr34-1933719112450335">34</xref>,<xref ref-type="bibr" rid="bibr36-1933719112450335">36</xref></sup></p>
<p>It is possible to estimate the degree of PKC activation by measuring the proportion of PKC found in the membrane compared to cytosolic PKC.<sup><xref ref-type="bibr" rid="bibr28-1933719112450335">28</xref>,<xref ref-type="bibr" rid="bibr37-1933719112450335">37</xref>,<xref ref-type="bibr" rid="bibr38-1933719112450335">38</xref></sup> In our study, we measured the degree of PKCα activation by comparing protein expression in membrane versus cytosol fractions. We observed that during myometrial quiescence (PT-NL), the larger proportion of PKCα is at the plasma membrane (active), and the degree of activation significantly decreased during myometrial activation (T-NL). This pattern of PKCα activation suggests that PKCα may contribute to the maintenance of myometrial quiescence and that a decrease in the activation of PKCα may mediate myometrial activation at the end of pregnancy. The degree of PKCα activation does not decrease further during myometrial stimulation (T-L), suggesting that an additional reduction in PKCα activity is not required to allow uterine contractions.</p>
<p>The larger proportion of PKCα in the particulate fraction during quiescence suggests increased PKCα activity but the kinase may be inactive. To confirm our suggestion, we measured PKCα activity in the fractions after PKCα immunoprecipitation using a PKC assay. We found increased PKCα activity during the period of myometrial quiescence, decreasing during myometrial activation. We conclude that PKCα translocation to the membranes during the period of myometrial quiescence is a reflection of an increase in PKCα activation.</p>
<p>A relevant finding of this research is the significant decrease in the activity of PKCα in the preterm labor group, which represents an early loss of myometrial quiescence. It is possible that the reduced activity of PKCα contributes to the loss of quiescence and the premature onset of labor. We recognize that the reduced activity of PKCα in the PT-L group may be the consequence of preterm labor and not its cause. However, our evidence demonstrating a reduction in PKCα activity at term pregnancy before the onset of labor suggests that the reduction in PKCα activity contributes to the mechanisms necessary to restore the contractile phenotype of myometrium (myometrial activation) and is not a consequence of uterine contractions.</p>
<p>We postulate that the reduced PKCα activity observed in the PT-L group may contribute to premature activation of the myometrium, which may lead to premature labor.</p>
<p>Premature termination of myometrial quiescence appears to be a plausible mechanism to explain a significant proportion of preterm labors. A better understanding of the mechanisms underlying myometrial quiescence and how it is altered in patients with preterm labor may be a way to develop new strategies for the prevention and treatment of preterm labor.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn1-1933719112450335"><label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-1933719112450335"><label>Funding</label>
<p>The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Fondo Nacional de Desarrollo Científico y Tecnológico de Chile [FONDECYT 1090616 and 1080163] and Pontificia Universidad Católica de Chile VRI [Puente 11/2012].</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1933719112450335">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Devane</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Begley</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Higgins</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>A systematic review and quality assessment of systematic reviews of fetal fibronectin and transvaginal length for predicting preterm birth</article-title>. <source>Eur J Obstet Gynecol Reprod Biol</source>. <year>2007</year>;<volume>133</volume>(<issue>2</issue>):<fpage>134</fpage>–<lpage>142</lpage>.</citation>
</ref>
<ref id="bibr2-1933719112450335">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Norwitz</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Challis</surname>
<given-names>JR</given-names>
</name>
</person-group>. <article-title>The control of labor</article-title>. <source>N Engl J Med</source>. <year>1999</year>;<volume>341</volume>(<issue>9</issue>):<fpage>660</fpage>–<lpage>666</lpage>.</citation>
</ref>
<ref id="bibr3-1933719112450335">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvajal</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>CP</given-names>
</name>
</person-group>. <article-title>Mechanisms underlying myometrial quiescence during pregnancy</article-title>. <source>Fetal and Maternal Medicine Review</source>. <year>2003</year>;<volume>14</volume>(<issue>3</issue>):<fpage>209</fpage>–<lpage>237</lpage>.</citation>
</ref>
<ref id="bibr4-1933719112450335">
<label>4</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Carvajal</surname>
<given-names>JA</given-names>
</name>
</person-group>. <article-title>Determinismo del Parto</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Pérez Sánchez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Donoso</surname>
<given-names>E</given-names>
</name>
</person-group>, eds. <source>Obstetricia. Cuarta Edición</source>. <publisher-loc>Santiago</publisher-loc>: <publisher-name>Editorial Mediterráneo Ltda</publisher-name>.; <year>2011</year>:<fpage>322</fpage>–<lpage>339</lpage>.</citation>
</ref>
<ref id="bibr5-1933719112450335">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buhimschi</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Yallampalli</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Garfield</surname>
<given-names>RE</given-names>
</name>
</person-group>. <article-title>Involvement of a nitric oxide-cyclic guanosine monophosphate pathway in control of human uterine contractility during pregnancy</article-title>. <source>Am J Obstet Gynecol</source>. <year>1995</year>;<volume>172</volume>(<issue>5</issue>):<fpage>1577</fpage>–<lpage>1584</lpage>.</citation>
</ref>
<ref id="bibr6-1933719112450335">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buxton</surname>
<given-names>IL</given-names>
</name>
<name>
<surname>Kaiser</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Malmquist</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Tichenor</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>NO-induced relaxation of labouring and non-labouring human myometrium is not mediated by cyclic GMP</article-title>. <source>Br J Pharmacol</source>. <year>2001</year>;<volume>134</volume>(<issue>1</issue>):<fpage>206</fpage>–<lpage>214</lpage>.</citation>
</ref>
<ref id="bibr7-1933719112450335">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvajal</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Buhimschi</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Aguan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>CP</given-names>
</name>
</person-group>. <article-title>Chorion releases a factor that inhibits oxytocin-stimulated myometrial contractility in the pregnant guinea pig</article-title>. <source>Hum Reprod</source>. <year>2001</year>;<volume>16</volume>(<issue>4</issue>):<fpage>638</fpage>–<lpage>643</lpage>.</citation>
</ref>
<ref id="bibr8-1933719112450335">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvajal</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Delpiano</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Cuello</surname>
<given-names>MA</given-names>
</name>
<etal/>
</person-group> <article-title>Brain natriuretic peptide (BNP) produced by the human chorioamnion may mediate pregnancy myometrial quiescence</article-title>. <source>Reprod Sci</source>. <year>2009</year>;<volume>16</volume>(<issue>1</issue>):<fpage>32</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr9-1933719112450335">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvajal</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>CP</given-names>
</name>
</person-group>. <article-title>Chorion-induced myometrial relaxation is mediated by large-conductance Ca2+-activated K+ channel opening in the guinea pig</article-title>. <source>Am J Obstet Gynecol</source>. <year>2003</year>;<volume>188</volume>(<issue>1</issue>):<fpage>84</fpage>–<lpage>91</lpage>.</citation>
</ref>
<ref id="bibr10-1933719112450335">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvajal</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Vidal</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Cuello</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Poblete</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>CP</given-names>
</name>
</person-group>. <article-title>Mechanisms of paracrine regulation by fetal membranes of human uterine quiescence</article-title>. <source>J Soc Gynecol Investig</source>. <year>2006</year>;<volume>13</volume>(<issue>5</issue>):<fpage>343</fpage>–<lpage>349</lpage>.</citation>
</ref>
<ref id="bibr11-1933719112450335">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buxton</surname>
<given-names>IL</given-names>
</name>
</person-group>. <article-title>Regulation of uterine function: a biochemical conundrum in the regulation of smooth muscle relaxation</article-title>. <source>Mol Pharmacol</source>. <year>2004</year>;<volume>65</volume>(<issue>5</issue>):<fpage>1051</fpage>–<lpage>1059</lpage>.</citation>
</ref>
<ref id="bibr12-1933719112450335">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez</surname>
<given-names>Bernal A</given-names>
</name>
</person-group>. <article-title>The regulation of uterine relaxation</article-title>. <source>Semin Cell Dev Biol</source>. <year>2007</year>;<volume>18</volume>(<issue>3</issue>):<fpage>340</fpage>–<lpage>347</lpage>.</citation>
</ref>
<ref id="bibr13-1933719112450335">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parker</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Murray-Rust</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>PKC at a glance</article-title>. <source>J Cell Sci</source>. <year>2004</year>;<volume>117</volume>(<issue>pt 2</issue>):<fpage>131</fpage>–<lpage>132</lpage>.</citation>
</ref>
<ref id="bibr14-1933719112450335">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breuiller-Fouche</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tertrin-Clary</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Heluy</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Fournier</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ferre</surname>
<given-names>F</given-names>
</name>
</person-group>. <article-title>Role of protein kinase C in endothelin-1-induced contraction of human myometrium</article-title>. <source>Biol Reprod</source>. <year>1998</year>;<volume>59</volume>(<issue>1</issue>):<fpage>153</fpage>–<lpage>159</lpage>.</citation>
</ref>
<ref id="bibr15-1933719112450335">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eude</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Paris</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cabrol</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ferre</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Breuiller-Fouche</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Selective protein kinase C isoforms are involved in endothelin-1-induced human uterine contraction at the end of pregnancy</article-title>. <source>Biol Reprod</source>. <year>2000</year>;<volume>63</volume>(<issue>5</issue>):<fpage>1567</fpage>–<lpage>1573</lpage>.</citation>
</ref>
<ref id="bibr16-1933719112450335">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eude-Le Parco</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Dallot</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Breuiller-Fouche</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Protein kinase C and human uterine contractility</article-title>. <source>BMC Pregnancy Childbirth</source>. <year>2007</year>;<volume>7</volume>(<issue>suppl 1</issue>):<fpage>S11</fpage>.</citation>
</ref>
<ref id="bibr17-1933719112450335">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hurd</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Fomin</surname>
<given-names>VP</given-names>
</name>
<name>
<surname>Natarajan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Bigsby</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>DM</given-names>
</name>
</person-group>. <article-title>Expression of protein kinase C isozymes in nonpregnant and pregnant human myometrium</article-title>. <source>Am J Obstet Gynecol</source>. <year>2000</year>;<volume>183</volume>(<issue>6</issue>):<fpage>1525</fpage>–<lpage>1531</lpage>.</citation>
</ref>
<ref id="bibr18-1933719112450335">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>Conventional-type protein kinase C contributes to phorbol ester-induced inhibition of rat myometrial tension</article-title>. <source>Br J Pharmacol</source>. <year>2003</year>;<volume>139</volume>(<issue>2</issue>):<fpage>408</fpage>–<lpage>414</lpage>.</citation>
</ref>
<ref id="bibr19-1933719112450335">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phillippe</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Protein kinase C, an inhibitor of oxytocin-stimulated phasic myometrial contractions</article-title>. <source>Biol Reprod</source>. <year>1994</year>;<volume>50</volume>(<issue>4</issue>):<fpage>855</fpage>–<lpage>859</lpage>.</citation>
</ref>
<ref id="bibr20-1933719112450335">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morrison</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Dearn</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Activation of protein kinase C is required for oxytocin-induced contractility in human pregnant myometrium</article-title>. <source>Hum Reprod</source>. <year>1996</year>;<volume>11</volume>(<issue>10</issue>):<fpage>2285</fpage>–<lpage>2290</lpage>.</citation>
</ref>
<ref id="bibr21-1933719112450335">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Liberto</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Dallot</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Eude-Le Parco</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Cabrol</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ferre</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Breuiller-Fouche</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>A critical role for PKC zeta in endothelin-1-induced uterine contractions at the end of pregnancy</article-title>. <source>Am J Physiol Cell Physiol</source>. <year>2003</year>;<volume>285</volume>(<issue>3</issue>):<fpage>C599</fpage>–<lpage>C607</lpage>.</citation>
</ref>
<ref id="bibr22-1933719112450335">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yasuda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nakamoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yasuhara</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Role of protein kinase Cbeta in rhythmic contractions of human pregnant myometrium</article-title>. <source>Reproduction</source>. <year>2007</year>;<volume>133</volume>(<issue>4</issue>):<fpage>797</fpage>–<lpage>806</lpage>.</citation>
</ref>
<ref id="bibr23-1933719112450335">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breuiller-Fouche</surname>
<given-names>M. PKC</given-names>
</name>
</person-group> isoforms in human uterine contractility. <article-title>Whodunit?</article-title> <source>Am J Obstet Gynecol</source>. <year>2004</year>;<volume>191</volume>(<issue>3</issue>):<fpage>1051</fpage>–<lpage>1052</lpage>.</citation>
</ref>
<ref id="bibr24-1933719112450335">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braz</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Gregory</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Pathak</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>PKC-alpha regulates cardiac contractility and propensity toward heart failure</article-title>. <source>Nat Med</source>. <year>2004</year>;<volume>10</volume>(<issue>3</issue>):<fpage>248</fpage>–<lpage>254</lpage>.</citation>
</ref>
<ref id="bibr25-1933719112450335">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hambleton</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hahn</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pleger</surname>
<given-names>ST</given-names>
</name>
<etal/>
</person-group> <article-title>Pharmacological- and gene therapy-based inhibition of protein kinase Calpha/beta enhances cardiac contractility and attenuates heart failure</article-title>. <source>Circulation</source>. <year>2006</year>;<volume>114</volume>(<issue>6</issue>):<fpage>574</fpage>–<lpage>582</lpage>.</citation>
</ref>
<ref id="bibr26-1933719112450335">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kooij</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Boontje</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zaremba</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group> <article-title>Protein kinase C alpha and epsilon phosphorylation of troponin and myosin binding protein C reduce Ca2+ sensitivity in human myocardium</article-title>. <source>Basic Res Cardiol</source>. <year>2010</year>;<volume>105</volume>(<issue>2</issue>):<fpage>289</fpage>–<lpage>300</lpage>.</citation>
</ref>
<ref id="bibr27-1933719112450335">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Macdonnell</surname>
<given-names>SM</given-names>
</name>
<etal/>
</person-group> <article-title>Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach</article-title>. <source>Circ Res</source>. <year>2009</year>;<volume>105</volume>(<issue>2</issue>):<fpage>194</fpage>–<lpage>200</lpage>.</citation>
</ref>
<ref id="bibr28-1933719112450335">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bermeo</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Fomin</surname>
<given-names>VP</given-names>
</name>
<name>
<surname>Ventolini</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gibbs</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>McKenna</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Hurd</surname>
<given-names>WW</given-names>
</name>
</person-group>. <article-title>Magnesium sulfate induces translocation of protein kinase C isoenzymes alpha and delta in myometrial cells from pregnant women</article-title>. <source>Am J Obstet Gynecol</source>. <year>2004</year>;<volume>190</volume>(<issue>2</issue>):<fpage>522</fpage>–<lpage>527</lpage>.</citation>
</ref>
<ref id="bibr29-1933719112450335">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chomczynski</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sacchi</surname>
<given-names>N</given-names>
</name>
</person-group>. <article-title>Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction</article-title>. <source>Anal Biochem</source>. <year>1987</year>;<volume>162</volume>(<issue>1</issue>):<fpage>156</fpage>–<lpage>159</lpage>.</citation>
</ref>
<ref id="bibr30-1933719112450335">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rozen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Skaletsky</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>Primer3 on the WWW for general users and for biologist programmers</article-title>. <source>Methods Mol Biol</source>. <year>2000</year>;<volume>132</volume>:<fpage>365</fpage>–<lpage>386</lpage>.</citation>
</ref>
<ref id="bibr31-1933719112450335">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruzycky</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Kulick</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Estrogen increases the expression of uterine protein kinase C isozymes in a tissue specific manner</article-title>. <source>Eur J Pharmacol</source>. <year>1996</year>;<volume>313</volume>(<issue>3</issue>):<fpage>257</fpage>–<lpage>263</lpage>.</citation>
</ref>
<ref id="bibr32-1933719112450335">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bieber</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Phillippe</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Tissue-specific protein kinase C isoform expression in rat uterine tissue</article-title>. <source>J Soc Gynecol Investig</source>. <year>1999</year>;<volume>6</volume>(<issue>6</issue>):<fpage>293</fpage>–<lpage>300</lpage>.</citation>
</ref>
<ref id="bibr33-1933719112450335">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozaki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yasuda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>YS</given-names>
</name>
<etal/>
</person-group> <article-title>Possible role of the protein kinase C/CPI-17 pathway in the augmented contraction of human myometrium after gestation</article-title>. <source>Br J Pharmacol</source>. <year>2003</year>;<volume>140</volume>(<issue>7</issue>):<fpage>1303</fpage>–<lpage>1312</lpage>.</citation>
</ref>
<ref id="bibr34-1933719112450335">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kheifets</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mochly-Rosen</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Insight into intra- and inter-molecular interactions of PKC: design of specific modulators of kinase function</article-title>. <source>Pharmacol Res</source>. <year>2007</year>;<volume>55</volume>(<issue>6</issue>):<fpage>467</fpage>–<lpage>476</lpage>.</citation>
</ref>
<ref id="bibr35-1933719112450335">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oancea</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Teruel</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Quest</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Green fluorescent protein (GFP)-tagged cysteine-rich domains from protein kinase C as fluorescent indicators for diacylglycerol signaling in living cells</article-title>. <source>J Cell Biol</source>. <year>1998</year>;<volume>140</volume>(<issue>3</issue>):<fpage>485</fpage>–<lpage>498</lpage>.</citation>
</ref>
<ref id="bibr36-1933719112450335">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mellor</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>PJ</given-names>
</name>
</person-group>. <article-title>The extended protein kinase C superfamily</article-title>. <source>Biochem J</source>. <year>1998</year>;<volume>332</volume>(<issue>pt 2</issue>):<fpage>281</fpage>–<lpage>292</lpage>.</citation>
</ref>
<ref id="bibr37-1933719112450335">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yaney</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Kirber</surname>
<given-names>MT</given-names>
</name>
</person-group>. <article-title>Modulation of Ca(2+) release through ryanodine receptors in vascular smooth muscle by protein kinase Calpha</article-title>. <source>Pflugers Arch</source>. <year>2010</year>;<volume>460</volume>(<issue>4</issue>):<fpage>791</fpage>–<lpage>802</lpage>.</citation>
</ref>
<ref id="bibr38-1933719112450335">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group> <article-title>Translocation of protein kinase C isoforms is involved in propofol-induced endothelial nitric oxide synthase activation</article-title>. <source>Br J Anaesth</source>. <year>2010</year>;<volume>104</volume>(<issue>5</issue>):<fpage>606</fpage>–<lpage>612</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>